Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Fulkerson

Neurological Surgery South Bend, IN Medical Doctor

NPI 1386802387 CMS profile 153195

100 Navarre Pl Ste 6600, South Bend, IN 46601

Open in the dashboard

General payments

$91,818

157 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Fulkerson of South Bend, IN is reported in the CMS Open Payments database as having received $91,818 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,768 26
2024 General $17,535 28
2023 General $22,843 25
2022 General $20,013 28
2021 General $6,427 18
2020 General $102 2
2019 General $6,129 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Fulkerson
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Daniel Fulkerson were reported at $18,768. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Daniel Fulkerson Neurological Surgery median Middle half National median
2019 $6,129 $582 $138–$3,006 $163
2020 $102 $294 $76–$2,174 $114
2021 $6,427 $387 $105–$2,432 $132
2022 $20,013 $542 $139–$2,989 $149
2023 $22,843 $534 $145–$2,697 $160
2024 $17,535 $574 $155–$3,046 $164
2025 $18,768 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aesculap, Inc. $71,686 76 payments
  2. Aesculap Implant Systems, LLC $15,563 1 payment
  3. Medtronic USA, Inc. $2,439 9 payments
  4. Medtronic, Inc. $336 4 payments
  5. Providence Medical Technology, Inc. $283 3 payments
  6. Alphatec Spine, Inc $209 3 payments
  7. Orthofix Medical, Inc. $205 9 payments
  8. Integra LifeSciences Corporation $186 9 payments
  9. SI-BONE, Inc. $122 4 payments
  10. AstraZeneca Pharmaceuticals LP $72 4 payments
  11. Other $717 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $70,399 8 payments
  2. Travel and Lodging $8,954 35 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,654 2 payments
  4. Food and Beverage $3,774 110 payments
  5. Education $38 2 payments
Products named General payments · program years 2019–2025
  1. PROGAV 2.0 $56,083 39 payments
  2. XABO $17,241 16 payments
  3. AESCULAP General Surgery $7,877 2 payments
  4. MINOP MODULAR NEUROENDOSCOPY SYSTEM $3,383 2 payments
  5. NO APPLICABLE MARKETED PRODUCT NAME $1,403 14 payments
  6. MazorX Renaissance $1,388 6 payments
  7. AESCULAP Surgical-Microscopes $1,197 2 payments
  8. CD HORIZON $1,050 3 payments
  9. PAEDIGAV $558 2 payments
  10. Other - Miscellaneous $209 3 payments
  11. Other $2,153 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$41,974

Medicare's payments for the services billed

Medicare patients

139

Average age 70

Services billed

246

67 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 50%
Depression 36%
Diabetes 32%
Chronic kidney disease 27%
Ischemic heart disease 24%
Atrial fibrillation 18%
COPD 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $20
$20 — —
WELIREG
  • Merck Sharp & Dohme Corporation $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record